HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katoh, H. Articles by Ichikawa, A. Search for Related Content PubMed PubMed Citation Articles by Katoh, H. Articles by Ichikawa, A. Social Bookmarking                      What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 29780-29784
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Prostaglandin E Receptor EP3 Subtype Induces Neurite Retraction via Small GTPase Rho

(Received for publication, April 30, 1996, and in revised form, August 26, 1996)

From the Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606, Japan

Prostaglandin E receptor EP3 subtype is widely distributed in the nervous system and is specifically localized to neurons, suggesting that the EP3 receptor plays important roles in the nervous system. We established a PC12 cell line that stably expresses the EP3B receptor isoform isolated from bovine adrenal chromaffin cells and examined the effect of agonist stimulation on the neuronal morphology of the PC12 cells. In the differentiated cells, M&B28767, an EP3 agonist, caused neurite retraction in a pertussis toxin-insensitive manner. 12-O-Tetradecanoylphorbol-13-acetate (TPA) also induced neurite retraction. However, when protein kinase C was down-regulated by long term exposure to TPA, TPA failed to induce neurite retraction, while the EP3B receptor-mediated retraction occurred normally. Clostridium botulinum C3 exoenzyme completely inhibited both EP3 agonist- and TPA-induced neurite retraction when microinjected into the cells, indicating that the morphological effect of the EP3B receptor is dependent on Rho activity. Thus, the activation of the EP3B receptor induced neurite retraction through a protein kinase C-independent Rho-activation pathway.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. M. Macias-Perez, R. Zent, M. Carmosino, M. D. Breyer, R. M. Breyer, and A. Pozzi Mouse EP3 {alpha}, {beta}, and {gamma} Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in Vivo J. Biol. Chem., May 2, 2008; 283(18): 12538 - 12545. [Abstract] [Full Text] [PDF]

				A.M. Patwardhan, J. Vela, J. Farugia, K. Vela, and K.M. Hargreaves Trigeminal Nociceptors Express Prostaglandin Receptors J. Dent. Res., March 1, 2008; 87(3): 262 - 266. [Abstract] [Full Text] [PDF]

				Y.-W. E. Chang, J. W. Marlin, T. W. Chance, and R. Jakobi RhoA Mediates Cyclooxygenase-2 Signaling to Disrupt the Formation of Adherens Junctions and Increase Cell Motility Cancer Res., December 15, 2006; 66(24): 11700 - 11708. [Abstract] [Full Text] [PDF]

				K. Shinmura, K. Tamaki, T. Sato, H. Ishida, and R. Bolli Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2093 - H2101. [Abstract] [Full Text] [PDF]

				E.-E. Govek, S. E. Newey, and L. Van Aelst The role of the Rho GTPases in neuronal development Genes & Dev., January 1, 2005; 19(1): 1 - 49. [Abstract] [Full Text] [PDF]

				G. Tamma, B. Wiesner, J. Furkert, D. Hahm, A. Oksche, M. Schaefer, G. Valenti, W. Rosenthal, and E. Klussmann The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho J. Cell Sci., August 15, 2003; 116(16): 3285 - 3294. [Abstract] [Full Text] [PDF]

				G. Gallo, H. F. Yee Jr., and P. C. Letourneau Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility J. Cell Biol., September 29, 2002; 158(7): 1219 - 1228. [Abstract] [Full Text] [PDF]

				S. Beqaj, S. Jakkaraju, R. R. Mattingly, D. Pan, and L. Schuger High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis J. Cell Biol., March 4, 2002; 156(5): 893 - 903. [Abstract] [Full Text] [PDF]

				K. L. Pierce, H. Fujino, D. Srinivasan, and J. W. Regan Activation of FP Prostanoid Receptor Isoforms Leads to Rho-mediated Changes in Cell Morphology and in the Cell Cytoskeleton J. Biol. Chem., December 10, 1999; 274(50): 35944 - 35949. [Abstract] [Full Text] [PDF]

				M. Majumdar, T. M. Seasholtz, C. Buckmaster, D. Toksoz, and J. H. Brown A Rho Exchange Factor Mediates Thrombin and Galpha 12-induced Cytoskeletal Responses J. Biol. Chem., September 17, 1999; 274(38): 26815 - 26821. [Abstract] [Full Text] [PDF]

				H. Hasegawa, H. Fujita, H. Katoh, J. Aoki, K. Nakamura, A. Ichikawa, and M. Negishi Opposite Regulation of Transepithelial Electrical Resistance and Paracellular Permeability by Rho in Madin-Darby Canine Kidney Cells J. Biol. Chem., July 23, 1999; 274(30): 20982 - 20988. [Abstract] [Full Text] [PDF]

				T. M. Seasholtz, M. Majumdar, and J. H. Brown MINIREVIEW: Rho as a Mediator of G Protein-Coupled Receptor Signaling Mol. Pharmacol., June 1, 1999; 55(6): 949 - 956. [Full Text]

				L. P. Audoly, L. Ma, I. Feoktistov, S. K. de Foe, M. D. Breyer, and R. M. Breyer Prostaglandin E-Prostanoid-3 Receptor Activation of Cyclic AMP Response Element-Mediated Gene Transcription J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 140 - 148. [Abstract] [Full Text]

				H. Katoh, J. Aoki, Y. Yamaguchi, Y. Kitano, A. Ichikawa, and M. Negishi Constitutively Active Galpha 12, Galpha 13, and Galpha q Induce Rho-dependent Neurite Retraction through Different Signaling Pathways J. Biol. Chem., October 30, 1998; 273(44): 28700 - 28707. [Abstract] [Full Text] [PDF]

				H. Katoh, J. Aoki, A. Ichikawa, and M. Negishi p160 RhoA-binding Kinase ROKalpha Induces Neurite Retraction J. Biol. Chem., January 30, 1998; 273(5): 2489 - 2492. [Abstract] [Full Text] [PDF]

				A. Hall Rho GTPases and the Actin Cytoskeleton Science, January 23, 1998; 279(5350): 509 - 514. [Abstract] [Full Text]

				F. M. Donovan, C. J. Pike, C. W. Cotman, and D. D. Cunningham Thrombin Induces Apoptosis in Cultured Neurons and Astrocytes via a Pathway Requiring Tyrosine Kinase and RhoA Activities J. Neurosci., July 15, 1997; 17(14): 5316 - 5326. [Abstract] [Full Text] [PDF]

				H. Togashi, K.-i. Nagata, M. Takagishi, N. Saitoh, and M. Inagaki Functions of a Rho-specific Guanine Nucleotide Exchange Factor in Neurite Retraction. POSSIBLE ROLE OF A PROLINE-RICH MOTIF OF KIAA0380 IN LOCALIZATION J. Biol. Chem., September 15, 2000; 275(38): 29570 - 29578. [Abstract] [Full Text] [PDF]

				S. Beqaj, S. Jakkaraju, R. R. Mattingly, D. Pan, and L. Schuger High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis J. Cell Biol., March 4, 2002; 156(5): 893 - 903. [Abstract] [Full Text] [PDF]